Low Dose Naltrexone's Utility for Non-Cancer Centralized Pain Conditions - A Scoping Review

Pain Med
11 June 2023

Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases

02 June 2023

Low-Dose Naltrexone in Rheumatological Diseases

Mediterr J Rheumatol
31 March 2023

Background: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders.

An Update on the Uses of Naltrexone in Clinical Practice

Natural Medicine Journal
01 August 2022


Marilyn - US: RA Pain (LDN; low dose naltrexone)